National Cancer Institute

Title (Tablepress)OrganizationLOI DateStart Time (Calender)Keywords
NCI Small Grants Program for Cancer Research for Years 2023, 2024, and 2025 (NCI Omnibus) (R03 Clinical Trial Optional)National Cancer Institute2/22/2024NCI, pilot,
Advanced Development and Validation of Emerging Biospecimen Science Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)National Cancer Institute3/1/20244/1/2024biospecimen science, technology development, validation, biobanking, tissue preservation, biomarkers, precision medicine
Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)National Cancer Institute3/1/20244/1/2024molecular analysis, cellular analysis, technology development, validation, diagnostics, therapeutics, drug development, precision medicine
Innovative Biospecimen Science Technologies for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)National Cancer Institute3/1/20244/1/2024biospecimens, biobanking, tissue preservation, biomarkers, genomics, proteomics, precision medicine
Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)National Cancer Institute3/1/20244/1/2024molecular analysis, cellular analysis, diagnostics, therapeutics, drug development, precision medicine, nanotechnology
Cancer Adoptive Cellular Therapy Network (Can-ACT) for Pediatric Cancers (UG3/UH3 Clinical Trial Required)National Cancer Institute3/6/20244/6/2024Pediatric cancer, adoptive cell therapy, solid tumors, clinical trials
National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trial Required)National Institutes of Health1/5/20246/5/2024clinical trials, early phase, treatment, diagnosis, innovative therapies
Development of Innovative Informatics Methods and Algorithms for Cancer Research and Management (R21 Clinical Trial Optional)National Cancer Institute5/11/20246/11/2024cancer informatics, algorithms, machine learning, artificial intelligence, data analysis, modeling
Sustained Support for Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional)National Cancer Institute5/11/20246/11/2024cancer informatics, clinical trials (optional), technology development, data management, research tools
Advanced Development of Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional)National Cancer Institute5/11/20246/11/2024cancer informatics, clinical trials (optional), technology development, early adopters, innovation
Early-Stage Development of Informatics Technologies for Cancer Research and Management (U01 Clinical Trial Optional)National Cancer Institute5/11/20246/11/2024cancer informatics, clinical trials (optional), technology development, proof-of-concept, feasibility
The NCI Predoctoral to Postdoctoral Fellow Transition Award (F99/K00 Clinical Trial Not Allowed)National Cancer Institute11/19/2024NCI, Predoctoral, Postdoctoral, Fellow Transition Award, Early Stage
Translational Research Toward Development of a Kaposi Sarcoma Herpesvirus (KSHV) Vaccine (U01 Clinical Trial Optional)National Cancer Institute11/4/202312/4/2024Kaposi sarcoma herpesvirus, virus, vaccine, therapeutic, innovation

Can’t find what you’re looking for? Please contact Researchadmin@cancer.ufl.edu for assistance in finding additional funding opportunities.

NCI Cancer Center badge